N@N

Liisa Bayko Maintained (VRTX) at Buy and Held Target at $260 on, May 3rd, 2021

Liisa Bayko of Evercore ISI Group, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy and Held Target at $260 on, May 3rd, 2021.

Liisa has made no other calls on VRTX in the last 4 months.

There are 8 other peers that have a rating on VRTX. Out of the 8 peers that are also analyzing VRTX, 2 agree with Liisa's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $254 on, Friday, April 30th, 2021
• Geoffrey Porges of "SVB Leerink" Maintained at Hold with Decreased Target to $250 on, Tuesday, February 2nd, 2021

These are the ratings of the 6 analyists that currently disagree with Liisa

---

• Brian Abrahams of "RBC Capital" Maintained at Buy with Decreased Target to $262 on, Friday, April 30th, 2021
• Gena Wang of "Barclays" Maintained at Buy and Held Target at $302 on, Wednesday, April 21st, 2021
• Brian Skorney of "Baird" Maintained at Buy and Held Target at $252 on, Tuesday, April 20th, 2021
• Do Kim of "BMO Capital" Maintained at Buy with Decreased Target to $284 on, Tuesday, February 2nd, 2021
• Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $347 on, Tuesday, February 2nd, 2021
• Evan Seigerman of "Credit Suisse" Maintained at Buy with Decreased Target to $280 on, Tuesday, February 2nd, 2021

Contributing Sources

---